Effect of Neural Stem Cells Derived From Autologous Bone Marrow Mesenchymal Stem Cell on Children with Cerebral Palsy in Clinical Trial

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-ONRC-11001679

Enrollment

Unknown

Registered

2011-11-05

Start date

2010-01-05

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Palsy

Interventions

Transplantation group:stem-cell transplantation

Control group:conventional methods

Eligibility

Sex/Gender

All

Age

1 Years to 5 Years

Inclusion criteria

Inclusion criteria: 1. Signed informed consent document; 2. Patients with CP were aged between 6 months to 12 years old; 3. Gross MotorFunction Classification System (GMFCS) levels III-V; 4. Their parents accepted voluntarily stem cell transplantation for theirchildren and followed-up.

Exclusion criteria

Exclusion criteria: 1. Have a history of severe allergic; 2. Serological tests such as AIDS, hepatitis B, syphilis, etc; 3. Hereditary metabolic diseases of nervous system; 4. Tumor or Hematological diseases.

Design outcomes

Primary

Measure	Time frame
GMFM socres;language quotien;	—

Countries

China

Contacts

Public ContactFeng Fang

fangfxy2003@yahoo.com.cn+86 13817290501

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026